Showing results (241-250 of 7,001) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|November 27, 2001
Neoadjuvant strategies for non-small cell lung cancerN van ZandwijkLung Cancer (Amsterdam, Netherlands)|November 27, 2001
Chemotherapy for advanced non-small cell lung cancer: standardsC ManegoldLung Cancer (Amsterdam, Netherlands)|December 25, 2002
Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapyC M Richardson, R A Sharma, G Cox, et al.Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Expression of thyroid transcription factor-1 in 16 human lung cancer cell linesJ Fujita, Y Ohtsuki, S Bandoh, et al.Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancerKazuro Sugi, Mikihisa Fukuda, Hiroshige Nakamura, et al.Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancerJ M Vieitez, M Valladares, M Gracia, et al.Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimensRoberto Petrioli, Daniele Pozzessere, Simona Messinese, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancerShigenori Kanazawa, Shosaku Nomura, Midori Kuwana, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatmentC J Hoekstra, S G Stroobants, O S Hoekstra, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas, in considering the indication of limited surgeryNaoki Ishiwa, Nobuo Ogawa, Akira Shoji, et al.Pageof 701